Early Phase Lentiviral Solutions for Cell Therapy

Plasmids that move discovery forward―fast

Optimizing transduction for a Lentiviral gene-modified cell therapy is tough—and choosing the wrong plasmids early can lead to costly delays and rework later. Aldevron gets it. That’s why we offer a high-quality lentiviral plasmid system designed to support smooth progression from discovery to clinic.

Reduce your workload and risk: spend time experimenting, not engineering

<div style="padding-top:40px;"></div>
  • Pre-designed lentiviral packaging plasmids for research, clinical, and commercial use
  • Designed for smooth progression—In-stock at research grade, GMP-Source™, and cGMP
  • Optimized for high-titer production
  • Packaging plasmids ship next day—no minimums, no waiting on custom preps
  • Custom transfer vector plasmid in as little as 72-hours

Phase-appropriate plasmids — get the quality you need when you need it

Aldevron pALD-Lenti packaging plasmids are optimized for lentiviral vector production to predictably and efficiently manufacture vectors for discovery, all the way through to clinical trials or commercial use.

RUO GMP-Source™ cGMP
In-stock packaging plasmids available
Custom transfer vector manufacturing available
QA Oversight
Regulatory support
Ideal for Discovery,
pre-clinical work
Tech transfer bridge Clinical & commercial use

Order Now

Order-pald-lenti
#f49600
Product Pack Size Catalog Number RG Purchase Option
pALD-LentiEGFP-K - RG 5 mg 5030-5 Buy Now
pALD-LentiEGFP-K - RG 10 mg 5030-10 Buy Now
pALD-Rev-K - RG 5 mg 5032-5 Buy Now
pALD-Rev-K - RG 10 mg 5032-10 Buy Now
pALD-VSV-G-K - RG 5 mg 5 mg 5036-5 Buy Now
pALD-VSV-G-K - RG 10 mg 10 mg 5036-10 Buy Now
pALD-GagPol-K - RG 5 mg 5034-5 Buy Now
pALD-GagPol-K - RG 10 mg 5034-10 Buy Now

Discuss your GMP-Source, cGMP, or custom manufacturing project with a plasmid expert.

Get in touch